John Hennessy, SVP of Strategy with Valuate Health, discusses the high cost of cancer care -- and how manufacturers, payers and clinicians are trying to address it. BONUS: John weighs in on the big Supreme Court decision on 340B payments.
John Hennessy, SVP of Strategy with Valuate Health Consultancy, is well known and highly respected for his experience in cancer care. In this episode, Hennessy discusses the high cost of cancer care -- and how manufacturers, payers and clinicians are trying to address it. He also reports back from the American Society of Clinical Oncology's first in-person meeting in two years.
BONUS: John weighs in on the big Supreme Court decision on 340B payments.
The IDI is presented by Valuate Health Consultancy. Follow Valuate on LinkedIn or visit us at ValuateHealth.com to learn more.